Varian Medical Systems and Johnson & Johnson Innovation – JJDC have returned for the series C-1 round having backed the U-M spinout's series C last year.

Capital One and Salesforce-backed cloud database provider Snowflake has confidentially filed for an initial public offering that could value it at up to $20bn.

Existing backer GV returned to take part in a $100m round for the clinical data software provider that also attracted new investor Regeneron Pharmaceuticals.

Johnson & Johnson and Varian Medical Systems are in line for exits after cancer therapy developer Fusion filed for a $100m initial public offering.

The cancer diagnostics technology developer, formed five years ago when Qiagen acquired part of Enzymatics, has filed to float on the Nasdaq Global Market.

Varian Medical Systems and Johnson & Johnson Innovation – JJDC returned for the series C-1 round having backed the histotripsy technology developer's series C last year.

McMaster University spinout Fusion Pharmaceuticals has filed for a $100m IPO in the US, putting shareholders such as Facit in line for exits.

Cash Capital has celebrated an exit as UCloudlink raised $36.2m in its offering, after pricing its shares at the bottom of the range and issuing less stock than originally planned.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The online car retailer will float in an upsized offering that represents an exit for AutoNation, having raised more than $720m in venture funding.